| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma R Salem, RJ Lewandowski, L Kulik, E Wang, A Riaz, RK Ryu, KT Sato, ... Gastroenterology 140 (2), 497-507. e2, 2011 | 744 | 2011 |
| Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection M Vouche, RJ Lewandowski, R Atassi, K Memon, VL Gates, RK Ryu, ... Journal of hepatology 59 (5), 1029-1036, 2013 | 271 | 2013 |
| Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization R Salem, M Gilbertsen, Z Butt, K Memon, M Vouche, R Hickey, T Baker, ... Clinical Gastroenterology and Hepatology 11 (10), 1358-1365. e1, 2013 | 261 | 2013 |
| Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis S Mouli, K Memon, T Baker, AB Benson III, MF Mulcahy, R Gupta, RK Ryu, ... Journal of Vascular and Interventional Radiology 24 (8), 1227-1234, 2013 | 222 | 2013 |
| Research reporting standards for radioembolization of hepatic malignancies R Salem, RJ Lewandowski, VL Gates, CW Nutting, R Murthy, SC Rose, ... Journal of vascular and interventional radiology: JVIR 22 (3), 265, 2011 | 197 | 2011 |
| Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times K Memon, L Kulik, RJ Lewandowski, E Wang, A Riaz, RK Ryu, KT Sato, ... Gastroenterology 141 (2), 526-535. e2, 2011 | 164 | 2011 |
| Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic–pathologic correlation A Riaz, K Memon, FH Miller, P Nikolaidis, LM Kulik, RJ Lewandowski, ... Journal of hepatology 54 (4), 695-704, 2011 | 159 | 2011 |
| Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes K Memon, RJ Lewandowski, MF Mulcahy, A Riaz, RK Ryu, KT Sato, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 887-894, 2012 | 157 | 2012 |
| Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression K Memon, L Kulik, RJ Lewandowski, MF Mulcahy, AB Benson, D Ganger, ... Journal of hepatology 58 (1), 73-80, 2013 | 141 | 2013 |
| Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis K Memon, L Kulik, RJ Lewandowski, E Wang, RK Ryu, A Riaz, ... Journal of hepatology 56 (5), 1112-1120, 2012 | 108 | 2012 |
| Radioembolization for primary and metastatic liver cancer K Memon, RJ Lewandowski, L Kulik, A Riaz, MF Mulcahy, R Salem Seminars in radiation oncology 21 (4), 294-302, 2011 | 104 | 2011 |
| Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study AB Benson III, JF Geschwind, MF Mulcahy, W Rilling, G Siskin, ... European Journal of Cancer 49 (15), 3122-3130, 2013 | 100 | 2013 |
| Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy RJ Lewandowski, K Memon, MF Mulcahy, R Hickey, K Marshall, ... European journal of nuclear medicine and molecular imaging 41, 1861-1869, 2014 | 97 | 2014 |
| Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients S Senthilnathan, K Memon, RJ Lewandowski, L Kulik, MF Mulcahy, ... Hepatology 55 (5), 1432-1442, 2012 | 89 | 2012 |
| Radiological‐pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90±sorafenib M Vouche, L Kulik, R Atassi, K Memon, R Hickey, D Ganger, FH Miller, ... Hepatology 58 (5), 1655-1666, 2013 | 88 | 2013 |
| Cancer concepts and principles: primer for the interventional oncologist—part II R Hickey, M Vouche, DY Sze, E Hohlastos, J Collins, T Schirmang, ... Journal of Vascular and Interventional Radiology 24 (8), 1167-1188, 2013 | 63 | 2013 |
| Yttrium 90 microspheres for the treatment of hepatocellular carcinoma K Memon, RJ Lewandowski, A Riaz, R Salem Multidisciplinary Treatment of Hepatocellular Carcinoma, 207-224, 2012 | 50 | 2012 |
| Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies K Memon, RJ Lewandowski, A Riaz, R Salem Current treatment options in oncology 13, 403-415, 2012 | 44 | 2012 |
| Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. N Hamoui, J Minocha, K Memon, K Sato, R Ryu, R Salem, ... Journal of vascular and interventional radiology: JVIR 24 (11), 1743-1745, 2013 | 43 | 2013 |
| Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization A Gabr, N Abouchaleh, R Ali, M Vouche, R Atassi, K Memon, A Al Asadi, ... European journal of radiology 93, 100-106, 2017 | 37 | 2017 |
